MORF4L1 and hepatocellular carcinoma: Moreover,CSCs have been reported to be involved in resistance to lenvatinib [14, 15], and response assays to lenvatinib demonstrated that MORF4L1 modulation significantly impacted drug sensitivity in HCC cell lines (Fig. 6M).